First line treatment of advanced non-small-cell lung cancer – specific focus on albumin bound paclitaxel

gan Gupta, Neha, Hatoum, Hassan, Dy, Grace K
Cyhoeddwyd 2013

Investigational agents in metastatic basal cell carcinoma: focus on vismodegib

gan Batty, Nicolas, Kossoff, Ellen, Dy, Grace K
Cyhoeddwyd yn J Exp Pharmacol (2012)

First-line cytotoxic chemotherapy regimen for non-small cell lung cancer in the elderly population: plus ça change

gan Dy, Grace K., Khalil, Maya, Yau, Edwin
Cyhoeddwyd yn Transl Lung Cancer Res (2020)

Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options

gan Desai, Arpita, Menon, Smitha P., Dy, Grace K.
Cyhoeddwyd yn Cancer Biol Med (2016)

First-line treatment of advanced ALK-positive non-small-cell lung cancer

gan Gandhi, Shipra, Chen, Hongbin, Zhao, Yujie, Dy, Grace K
Cyhoeddwyd yn Lung Cancer (Auckl) (2015)

The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer

gan Crombet Ramos, Tania, Santos Morales, Orestes, Dy, Grace K., León Monzón, Kalet, Lage Dávila, Agustín
Cyhoeddwyd yn Front Oncol (2021)

Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways

gan Zhang, Hao, Shao, Huanjie, Golubovskaya, Vita M, Chen, Hongbin, Cance, William, Adjei, Alex A, Dy, Grace K
Cyhoeddwyd yn Br J Cancer (2016)

Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer†

gan Yendamuri, Sai, Groman, Adrienne, Miller, Austin, Demmy, Todd, Hennon, Mark, Dexter, Elisabeth, Picone, Anthony, Nwogu, Chukwumere, Dy, Grace K
Cyhoeddwyd yn Eur J Cardiothorac Surg (2018)

The Prognostic Significance of Focal Adhesion Kinase (FAK) Expression in Stage I Non-Small Cell Lung Cancer

gan Dy, Grace K., Ylagan, Lourdes, Pokharel, Saraswati, Miller, Austin, Brese, Elizabeth, Bshara, Wiam, Morrison, Carl, Cance, William G., Golubovskaya, Vita M.
Cyhoeddwyd 2014

Concomitant Mediastinoscopy Increases the Risk of Post-operative Pneumonia after Pulmonary Lobectomy

gan Yendamuri, Sai, Battoo, Athar, Attwood, Kris, Dhillon, Samjot Singh, Dy, Grace K., Hennon, Mark, Picone, Anthony, Nwogu, Chukwumere, Demmy, Todd, Dexter, Elisabeth
Cyhoeddwyd yn Ann Surg Oncol (2018)

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature

gan Agrawal, Nikhil, Khunger, Arjun, Vachhani, Pankit, Colvin, Teresa A., Hattoum, Alexander, Spangenthal, Edward, Curtis, Anne B., Dy, Grace K., Ernstoff, Marc S., Puzanov, Igor
Cyhoeddwyd yn Case Rep Oncol (2019)

Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance

gan Shaurova, Tatiana, Dy, Grace K, Battaglia, Sebastiano, Hutson, Alan, Zhang, Letian, Zhang, Yunkai, Lovly, Christine M, Seshadri, Mukund, Goodrich, David W, Johnson, Candace S, Hershberger, Pamela A
Cyhoeddwyd yn Cancers (Basel) (2020)

Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144

gan Dy, Grace K., Hobday, Timothy J., Nelson, Garth, Windschitl, Harold E., O’Connell, Michael J., Alberts, Steven R., Goldberg, Richard M., Nikcevich, Daniel A., Sargent, Daniel J.
Cyhoeddwyd 2009

Correlation Between Polymorphisms of the Reduced Folate Carrier Gene (SLC19A1) and Survival After Pemetrexed-Based Therapy in Non-small Cell Lung Cancer: A North Central Cancer Tre...

gan Adjei, Araba A., Salavaggione, Oreste E., Mandrekar, Sumithra J., Dy, Grace K., Allen Ziegler, Katie L., Endo, Chiaki, Molina, Julian R., Schild, Steven E., Adjei, Alex A.
Cyhoeddwyd yn J Thorac Oncol (2010)

Body mass index (BMI) Influences the Salutary Effects of Metformin on Survival After Lobectomy for Stage I NSCLC

gan Yendamuri, Sai, Barbi, Joseph, Pabla, Sarabjot, Petrucci, Cara, Punnanitinont, Achamaporn, Nesline, Mary, Glenn, Sean T., Depietro, Paul, Papanicalou-Sengos, Antonios, Morrison, Carl, Dy, Grace K., Elkin, Peter L.
Cyhoeddwyd yn J Thorac Oncol (2019)

A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors

gan Adjei, Alex A., LoRusso, Patricia, Ribas, Antoni, Sosman, Jeffrey A., Pavlick, Anna, Dy, Grace K., Zhou, Xiaofei, Gangolli, Esha, Kneissl, Michelle, Faucette, Stephanie, Neuwirth, Rachel, Bózon, Viviana
Cyhoeddwyd yn Invest New Drugs (2016)

A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)– A North Central Cancer Treatment Group Study N0326()...

gan Dy, Grace K., Hillman, Shauna L., Rowland, Kendrith M., Molina, Julian R., Steen, Preston D., Wender, Donald B., Nair, Suresh, Mandrekar, Sumithra, Schild, Steven E., Adjei, Alex A.
Cyhoeddwyd yn Cancer (2010)

Co-relation of Overall Survival with Peripheral Blood-Based Inflammatory Biomarkers in Advanced Stage Non-Small Cell Lung Cancer Treated with Anti-Programmed Cell Death-1 Therapy:...

gan Naqash, Abdul Rafeh, Stroud, Chipman Robert Geoffrey, Butt, Muhammad Umer, Hegde, Aparna, Dy, Grace K., Muzaffar, Mahvish, Yang, Li V., Cherry, Cynthia R., Hafiz, Maida, Walker, Paul R.
Cyhoeddwyd yn Acta Oncol (2017)

NCCTG N0821 (Alliance): A phase II first-line study of pemetrexed, carboplatin and bevacizumab in elderly patients with advanced nonsquamous non-small cell lung cancer with good pe...

gan Dy, Grace K., Molina, Julian R., Qi, Yingwei, Ansari, Rafat, Thomas, Sachdev, Ross, Helen J., Soori, Gamini, Anderson, Daniel, Aubry, Marie Christine, Meyers, Jeffrey, Adjei, Araba A., Mandrekar, Sumithra, Adjei, Alex A.
Cyhoeddwyd 2014

Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426

gan Adjei, Alex A., Mandrekar, Sumithra J., Dy, Grace K., Molina, Julian R., Adjei, Araba A., Gandara, David R., Ziegler, Katie L. Allen, Stella, Philip J., Rowland, Kendrith M., Schild, Steven E., Zinner, Ralph G.
Cyhoeddwyd 2010